[1]
Ehrlich J, Bartz QR, Smith RM, Joslyn DA, Burkholder PR. Chloromycetin, a New Antibiotic From a Soil Actinomycete. Science (New York, N.Y.). 1947 Oct 31:106(2757):417
[PubMed PMID: 17737966]
[2]
Paris DH, Dumler JS. State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus. Current opinion in infectious diseases. 2016 Oct:29(5):433-9. doi: 10.1097/QCO.0000000000000298. Epub
[PubMed PMID: 27429138]
Level 3 (low-level) evidence
[3]
Mirecka A. Etiological agents of bacterial meningitis in adults and antibiotic susceptibility of Streptococcus pneumoniae isolated between 2009-2016 from patients of Regional Specialist Hospital of Dr Wł. Biegański in Lódź. Przeglad epidemiologiczny. 2018:72(3):313-324
[PubMed PMID: 30394054]
[4]
Sudarsanam TD, Rupali P, Tharyan P, Abraham OC, Thomas K. Pre-admission antibiotics for suspected cases of meningococcal disease. The Cochrane database of systematic reviews. 2017 Jun 14:6(6):CD005437. doi: 10.1002/14651858.CD005437.pub4. Epub 2017 Jun 14
[PubMed PMID: 28613408]
Level 3 (low-level) evidence
[5]
Patil N, Mule P. Sensitivity Pattern Of Salmonella typhi And Paratyphi A Isolates To Chloramphenicol And Other Anti-Typhoid Drugs: An In Vitro Study. Infection and drug resistance. 2019:12():3217-3225. doi: 10.2147/IDR.S204618. Epub 2019 Oct 14
[PubMed PMID: 31686872]
[6]
NAGAO I. Comparative study of roseomycin, streptomycin, chloramphenicol and homosulfanilamide on the effect of experimental cholera infections. The Tohoku journal of experimental medicine. 1953:58(2):191-4
[PubMed PMID: 13136153]
Level 2 (mid-level) evidence
[7]
Erel E, Platt AJ, Ramakrishnan V. Chloramphenicol use in plastic surgery. British journal of plastic surgery. 1999 Jun:52(4):326-7
[PubMed PMID: 10624313]
[8]
Shen AY, Haddad EJ, Hunter-Smith DJ, Rozen WM. Efficacy and adverse effects of topical chloramphenicol ointment use for surgical wounds: a systematic review. ANZ journal of surgery. 2018 Dec:88(12):1243-1246. doi: 10.1111/ans.14465. Epub 2018 Mar 23
[PubMed PMID: 29573103]
Level 1 (high-level) evidence
[9]
Brook I. Antimicrobials therapy of anaerobic infections. Journal of chemotherapy (Florence, Italy). 2016 Jun:28(3):143-50. doi: 10.1179/1973947815Y.0000000068. Epub
[PubMed PMID: 26365224]
[10]
Dinos GP,Athanassopoulos CM,Missiri DA,Giannopoulou PC,Vlachogiannis IA,Papadopoulos GE,Papaioannou D,Kalpaxis DL, Chloramphenicol Derivatives as Antibacterial and Anticancer Agents: Historic Problems and Current Solutions. Antibiotics (Basel, Switzerland). 2016 Jun 3;
[PubMed PMID: 27271676]
[12]
Schlünzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 2001 Oct 25:413(6858):814-21
[PubMed PMID: 11677599]
[13]
Flach AJ. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. American journal of ophthalmology. 1982 Sep:94(3):420-2
[PubMed PMID: 7124889]
[14]
West BC, DeVault GA Jr, Clement JC, Williams DM. Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine. Reviews of infectious diseases. 1988 Sep-Oct:10(5):1048-51
[PubMed PMID: 3055188]
Level 3 (low-level) evidence
[15]
Barnhill AE, Brewer MT, Carlson SA. Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components. Antimicrobial agents and chemotherapy. 2012 Aug:56(8):4046-51. doi: 10.1128/AAC.00678-12. Epub 2012 May 21
[PubMed PMID: 22615289]
[16]
Fraumeni JF Jr. Bone marrow depression induced by chloramphenicol or phenylbutazone. Leukemia and other sequelae. JAMA. 1967 Sep 11:201(11):828-34
[PubMed PMID: 6071896]
[17]
Macfadyen CA, Acuin JM, Gamble C. Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. The Cochrane database of systematic reviews. 2006 Jan 25:(1):CD005608
[PubMed PMID: 16437533]
Level 1 (high-level) evidence
[18]
Andicochea CT, Portouw SJ, Bokan MM. Chloramphenicol and acute esophagitis in the emergency department. Journal of emergencies, trauma, and shock. 2015 Jan-Mar:8(1):65-7. doi: 10.4103/0974-2700.150401. Epub
[PubMed PMID: 25709259]
[19]
Kuroda S, Tateishi J, Otsuki S. Neurotoxicity with chloramphenicol--an electron microscopic study. Folia psychiatrica et neurologica japonica. 1975:29(1):39-46
[PubMed PMID: 1158315]
[20]
Wiest DB, Cochran JB, Tecklenburg FW. Chloramphenicol toxicity revisited: a 12-year-old patient with a brain abscess. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2012 Apr:17(2):182-8. doi: 10.5863/1551-6776-17.2.182. Epub
[PubMed PMID: 23118672]
[21]
Wong Sh, Silva F, Acheson J, Plant G. An old friend revisited: chloramphenicol optic neuropathy. JRSM short reports. 2013 Mar:4(3):20. doi: 10.1177/2042533313476692. Epub 2013 Mar 6
[PubMed PMID: 23560219]
[22]
Godel V, Nemet P, Lazar M. Chloramphenicol optic neuropathy. Archives of ophthalmology (Chicago, Ill. : 1960). 1980 Aug:98(8):1417-21
[PubMed PMID: 7417077]
[23]
Thadani H, Deacon A, Peters T. Diagnosis and management of porphyria. BMJ (Clinical research ed.). 2000 Jun 17:320(7250):1647-51
[PubMed PMID: 10856069]
[24]
Mehta M, Rath GP, Padhy UP, Marda M, Mahajan C, Dash HH. Intensive care management of patients with acute intermittent porphyria: Clinical report of four cases and review of literature. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2010 Apr:14(2):88-91. doi: 10.4103/0972-5229.68222. Epub
[PubMed PMID: 20859493]
Level 3 (low-level) evidence
[25]
Liphshitz I, Loewenstein A. Anaphylactic reaction following application of chloramphenicol eye ointment. The British journal of ophthalmology. 1991 Jan:75(1):64
[PubMed PMID: 1991092]
[26]
Livingston RJ, Butterworth JW, Belt P. Reaction or infection: topical chloramphenicol treatment. Annals of the Royal College of Surgeons of England. 2013 Jan:95(1):e20-1
[PubMed PMID: 23317719]
[27]
Thomseth V, Cejvanovic V, Jimenez-Solem E, Petersen KM, Poulsen HE, Andersen JT. Exposure to topical chloramphenicol during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study. Acta ophthalmologica. 2015 Nov:93(7):651-3. doi: 10.1111/aos.12737. Epub 2015 Apr 28
[PubMed PMID: 25923453]
[28]
Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy. European journal of epidemiology. 2000 Apr:16(4):323-7
[PubMed PMID: 10959939]
Level 2 (mid-level) evidence
[29]
Chung CY, Kwok AK, Chung KL. Use of ophthalmic medications during pregnancy. Hong Kong medical journal = Xianggang yi xue za zhi. 2004 Jun:10(3):191-5
[PubMed PMID: 15181224]
[30]
Wenk M, Vozeh S, Follath F. Serum level monitoring of antibacterial drugs. A review. Clinical pharmacokinetics. 1984 Nov-Dec:9(6):475-92
[PubMed PMID: 6391780]
[32]
SUTHERLAND JM. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. A.M.A. journal of diseases of children. 1959 Jun:97(6):761-7
[PubMed PMID: 13649107]
[33]
Mulhall A, de Louvois J, Hurley R. Chloramphenicol toxicity in neonates: its incidence and prevention. British medical journal (Clinical research ed.). 1983 Nov 12:287(6403):1424-7
[PubMed PMID: 6416440]
[34]
Craft AW, Brocklebank JT, Hey EN, Jackson RH. The 'grey toddler'. Chloramphenicol toxicity. Archives of disease in childhood. 1974 Mar:49(3):235-7
[PubMed PMID: 4825630]